Clinovo taps Life Sciences executive Nandish Poluru as its next Chief Executive Officer
Retrieved on:
Thursday, August 18, 2022
Laboratory, Forest Laboratories, Electrical engineering, Operations and technology management, Drug, Technology, Growth, Clinical, Health, Cleveland State University, Information, Master, Bristol Myers Squibb, BMS, SAN, Foundation, Research and development, Globe, Sri Venkateswara University, Yale School of Management, List of life sciences, Research, Clinical data management, MBA, University, Regulation, Digital health, Development, Clinical research, Pharmaceutical industry, Management, Silicon, Biostatistics, Allergan, Edwards Lifesciences, Nandish Sandhu, Pharmacovigilance
SAN JOSE, Calif., Aug. 18, 2022 /PRNewswire/ -- Clinovo, a technology focused Clinical services provider that accelerates Clinical Development for Life Sciences industry appoints Nandish Poluru as Chief Executive Officer effective immediately.
Key Points:
- SAN JOSE, Calif., Aug. 18, 2022 /PRNewswire/ -- Clinovo, a technology focused Clinical services provider that accelerates Clinical Development for Life Sciences industry appoints Nandish Poluru as Chief Executive Officer effective immediately.
- Prior to BMS, Nandish was Executive Director at Allergan (an Abbvie company) and worked at Forest Laboratories in various roles.
- "It is with great excitement and immense pleasure that I welcome Nandish to Clinovo" said Vamsi Maddipatla, President and Chairman at Clinovo.
- Clinovo works with life sciences customers across the globe to accelerate clinical development and bring new medicines to market faster.